Clinical Trials Directory

Trials / Sponsors / Chiron Corporation

Chiron Corporation

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedTezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
Esophageal Neoplasms, Stomach Neoplasms, Adenocarcinoma
Phase 22003-11-01
UnknownKinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine
Meningococcal Disease; Meningococcal Meningitis
Phase 42003-09-01
TerminatedTezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Colorectal Neoplasms
Phase 22003-06-01
UnknownSafety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
HIV Infections
Phase 11999-08-01
TerminatedComparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgk
Non-Hodgkin Lymphoma
Phase 2—
CompletedA Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
HIV Infections
Phase 1—
CompletedSafety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positi
HIV Infections
N/A—
CompletedA Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Th
Cytomegalovirus Retinitis, HIV Infections
Phase 1—
CompletedProleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Lymphoma, Non-Hodgkin
Phase 2—
CompletedA Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy
HIV Infections, HIV Seronegativity
Phase 1—
CompletedProleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Fa
Lymphoma, Non-Hodgkin
Phase 2 / Phase 3—